Skip to content

MDMA for depression: all studies

Page 6 of 6: studies 51 to 54 of 54, newest first. Back to the MDMA for depression overview

Research

Recreational ecstasy use and depression.

Journal of Psychopharmacology May 2006 Casey R. Guillot, David Greenway

Research in laboratory animals has shown that 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) destroys serotonergic axons in the brain at certain doses. Serotonin is known to take part in the regulation of mood in humans. Many researchers have hypothesized that if recreational ecstasy use destroys serotonergic axons, then a corresponding decline in the mood of ecstasy users should be seen....

Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study

BMJ February 24, 2006 Anja C. Huizink, Robert F Ferdinand, Jan Van der Ende et al. 77 citations

OBJECTIVE: To investigate whether using ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is preceded by symptoms of behavioural and emotional problems in childhood and early adolescence. DESIGN: Prospective, longitudinal, population based study SETTING: The Dutch province of Zuid-Holland. PARTICIPANTS: A sample of 1580 individuals, followed up across a 14 year period, from childhood into...

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

Psychopharmacology May 2004 Jonathan P. Roiser, Barbara J. Sahakian

3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") causes serotonin neuron damage in laboratory animals. The serotonin system is known to be important in the regulation of mood. Previous research has shown that MDMA users score higher on self-report ratings of depression than controls. However, MDMA users commonly take other illicit substances and many studies do not fully control for...

MDMA Assisted Psychotherapy Decreases PTSD Symptoms, Dissociation, Functional Disability, and Depression: A Systematic Review and Meta-Analysis

medRxiv Warwick M. Green, Sanket B Raut, F.l.j. James et al. 4 citations preprint

Abstract Post-Traumatic Stress Disorder (PTSD) causes broad impairments affecting quality of life. However, despite current treatment many people with PTSD do not fully recover. MDMA assisted psychotherapy has emerged as a new therapy for PTSD and its comorbidities. We aimed to analyse the current evidence for MDMA assisted psychotherapy in PTSD and associated quality of life, and physiological...